FDA Inspection 1120574 — NattoPharma USA, Inc.
The FDA completed an inspection of NattoPharma USA, Inc. on February 18, 2020 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 18, 2020
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- East Brunswick, NJ (United States)